Grant: Master's Award: Canada Graduate Scholarships
McMaster University
$17,500.00
Investigating Genetic Reprogramming of Macrophages by Glioblastoma Stem Cells
EF 2023-24
Résumé
Glioblastoma (GBM), the most common primary brain cancer, has a median survival of 8 months despite an aggressive treatment regime. Brain Tumour Initiating Cells (BTICs) are a small population of GBM cells that resemble stem cells and contribute to high genetic diversity, making GBM a very difficult cancer to treat. BTICs interact with other cancer cells, as well as non-cancerous cells present in the tumour. The predominant non-cancerous cell in GBM are macrophages, immune cells which are largely responsible for engulfing and clearing pathogens and stressed cells through a process called phagocytosis. Interestingly, macrophages display impaired phagocytic activity in GBM, and even contribute to malignancy. This study aims to understand how GBM BTICs and macrophages communicate, and how to turn macrophages into anti-tumour effectors. We will first analyze gene expression changes in patient-derived BTICs and macrophages after these cell types are cultured together to understand how they communicate with each other. Secondly, we will use the genetic tool CRISPR to determine which genes in macrophages are involved in tumour phagocytosis. This will be done by systematically inactivating each of the ~18,000 genes in the genome, then injecting these cells in mice brains along with mouse glioma cells. Afterwards, we will harvest these brains to determine which genes are essential to promote tumor elimination by macrophages. This approach aims to identify specific genes that, when knocked out, enhance tumour clearance. By combining these approaches, we hope to reveal new insights into the BTIC-macrophage interaction at the molecular level. Ultimately, this will lead to innovative ways to reprogram macrophages, turning them into powerful allies against brain tumours.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
506075
Name
Grewal Shan
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating Genetic Reprogramming of Macrophages by Glioblastoma Stem Cells
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer Immunology; Glioblastoma; Immunotherapy; Tumour-Associated Macrophages
Abstract
Glioblastoma (GBM), the most common primary brain cancer, has a median survival of 8 months despite an aggressive treatment regime. Brain Tumour Initiating Cells (BTICs) are a small population of GBM cells that resemble stem cells and contribute to high genetic diversity, making GBM a very difficult cancer to treat. BTICs interact with other cancer cells, as well as non-cancerous cells present in the tumour. The predominant non-cancerous cell in GBM are macrophages, immune cells which are largely responsible for engulfing and clearing pathogens and stressed cells through a process called phagocytosis. Interestingly, macrophages display impaired phagocytic activity in GBM, and even contribute to malignancy. This study aims to understand how GBM BTICs and macrophages communicate, and how to turn macrophages into anti-tumour effectors. We will first analyze gene expression changes in patient-derived BTICs and macrophages after these cell types are cultured together to understand how they communicate with each other. Secondly, we will use the genetic tool CRISPR to determine which genes in macrophages are involved in tumour phagocytosis. This will be done by systematically inactivating each of the ~18,000 genes in the genome, then injecting these cells in mice brains along with mouse glioma cells. Afterwards, we will harvest these brains to determine which genes are essential to promote tumor elimination by macrophages. This approach aims to identify specific genes that, when knocked out, enhance tumour clearance. By combining these approaches, we hope to reveal new insights into the BTIC-macrophage interaction at the molecular level. Ultimately, this will lead to innovative ways to reprogram macrophages, turning them into powerful allies against brain tumours.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Grewal, Shan
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~